-
1
-
-
0038206660
-
Managing taxane toxicities
-
Markman M.Managing taxane toxicities.Support Care Cancer. 2003;11 (3): 144-147.
-
(2003)
Support Care Cancer
, vol.11
, Issue.3
, pp. 144-147
-
-
Markman, M.1
-
2
-
-
43049128141
-
Peripheral nerve damage associated with administration of taxanes in patients with cancer
-
Argyriou AA,Koltzenburg M,Polychronopoulos P,Papapetropoulos S,Kalofonos P.Peripheral nerve damage associated with administration of taxanes in patients with cancer.Crit Rev Oncol Hematol. 2008;66 (3): 218-228.
-
(2008)
Crit Rev Oncol Hematol
, vol.66
, Issue.3
, pp. 218-228
-
-
Argyriou, A.A.1
Koltzenburg, M.2
Polychronopoulos, P.3
Papapetropoulos, S.4
Kalofonos, P.5
-
3
-
-
33745607370
-
New and emerging treatment options for neuropathic pain
-
Gidal BE.New and emerging treatment options for neuropathic pain.Am J Manag Care. 2006;12 (9 suppl): S269-S278.
-
(2006)
Am J Manag Care
, vol.12
, Issue.9 SUPPL.
-
-
Gidal, B.E.1
-
4
-
-
33750812245
-
Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rat: evidence for synergism between serotonergic and noradrenergic reuptake inhibition
-
Jones CK,Eastwood BJ,Need AB,Shannon HE.Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rat: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.Neuropharmacology. 2006;51 (7-8): 1172-1180.
-
(2006)
Neuropharmacology
, vol.51
, Issue.7-8
, pp. 1172-1180
-
-
Jones, C.K.1
Eastwood, B.J.2
Need, A.B.3
Shannon, H.E.4
-
5
-
-
84885748985
-
-
Common Terminology Criteria for Adverse Events (CTCAE) Version 4.02. Accessed October 15, 2009
-
Common Terminology Criteria for Adverse Events (CTCAE) Version 4.02. Accessed October 15, 2009.
-
-
-
-
6
-
-
0027228024
-
Clinical toxicities encountered with paclitaxel (Taxol)
-
Rowinsky EK,Eisenhauer EA,Chaudhry V,Arbuck SG,Donehower RC.Clinical toxicities encountered with paclitaxel (Taxol).Semin Oncol. 1993;20 (4 suppl 3): 1-15.
-
(1993)
Semin Oncol
, vol.20
, Issue.4 SUPPL. 3
, pp. 1-15
-
-
Rowinsky, E.K.1
Eisenhauer, E.A.2
Chaudhry, V.3
Arbuck, S.G.4
Donehower, R.C.5
-
7
-
-
0034235226
-
Mechanism of paclitaxel activity in Kaposi's sarcoma
-
Sgadari C,Tosdhi E,Palladino C, et al.Mechanism of paclitaxel activity in Kaposi's sarcoma.J Immunol. 2000;165 (1): 509-517.
-
(2000)
J Immunol
, vol.165
, Issue.1
, pp. 509-517
-
-
Sgadari, C.1
Tosdhi, E.2
Palladino, C.3
-
8
-
-
45949131693
-
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies
-
Wolf S,Barton D,Kottschade L,Grothey A,Loprinzi C.Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.Eur J Cancer. 2008;44 (11): 1507-1515.
-
(2008)
Eur J Cancer
, vol.44
, Issue.11
, pp. 1507-1515
-
-
Wolf, S.1
Barton, D.2
Kottschade, L.3
Grothey, A.4
Loprinzi, C.5
-
9
-
-
0034896277
-
Reduction of paclitaxel-induced peripheral neuropathy with glutamine
-
Vahdat L,Papadopoulos K,Lange D, et al.Reduction of paclitaxel-induced peripheral neuropathy with glutamine.Clin Cancer Res. 2001;7 (5): 1192-1197.
-
(2001)
Clin Cancer Res
, vol.7
, Issue.5
, pp. 1192-1197
-
-
Vahdat, L.1
Papadopoulos, K.2
Lange, D.3
-
10
-
-
84885718066
-
Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer
-
[published online November 22, 2011]
-
Tanabe Y,Hashimoto K,Shimizu C, et al.Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer [published online November 22, 2011].Int J Clin Oncol. 2011;:.
-
(2011)
Int J Clin Oncol
-
-
Tanabe, Y.1
Hashimoto, K.2
Shimizu, C.3
-
11
-
-
0041329867
-
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
-
du Bois A,Lück HJ,Meier W, et al.A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.J Natl Cancer Inst. 2003;95 (17): 1320-1329.
-
(2003)
J Natl Cancer Inst
, vol.95
, Issue.17
, pp. 1320-1329
-
-
du Bois, A.1
Lück, H.J.2
Meier, W.3
-
12
-
-
0028901936
-
Peripheral neurotoxicity of taxol in patients previously treated with cisplatin
-
Cavaletti G,Bogliun G,Marzorati L, et al.Peripheral neurotoxicity of taxol in patients previously treated with cisplatin.Cancer. 1995;75 (5): 1141-1150.
-
(1995)
Cancer
, vol.75
, Issue.5
, pp. 1141-1150
-
-
Cavaletti, G.1
Bogliun, G.2
Marzorati, L.3
-
13
-
-
77950367410
-
Recommendation for the pharmacological management of neuropathic pain: an overview and literature update
-
Dworkin RH,O'Connor AB,Audette J, et al.Recommendation for the pharmacological management of neuropathic pain: an overview and literature update.Mayo Clin Proc. 2010;85 (3 suppl): S3-S14.
-
(2010)
Mayo Clin Proc
, vol.85
, Issue.3 SUPPL.
-
-
Dworkin, R.H.1
O'Connor, A.B.2
Audette, J.3
-
14
-
-
72049131297
-
Comparison of mechanical allodynia and the affective component of inflammatory pain in rats
-
Boyce-Rustay JM,Zhong C,Kohnken R, et al.Comparison of mechanical allodynia and the affective component of inflammatory pain in rats.Neuropharmacology. 2010;58 (2): 537-543.
-
(2010)
Neuropharmacology
, vol.58
, Issue.2
, pp. 537-543
-
-
Boyce-Rustay, J.M.1
Zhong, C.2
Kohnken, R.3
-
15
-
-
84867571990
-
CALGB 170601: a phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN)
-
(abstr CRA9013)
-
Lavoe smith EM,Pang H,Cirrincione C, et al.CALGB 170601: a phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN).J Clin Oncol. 2012;30 ((suppl; abstr CRA9013)):.
-
(2012)
J Clin Oncol
, vol.30
, Issue.SUPPL.
-
-
Lavoe smith, E.M.1
Pang, H.2
Cirrincione, C.3
|